Gamma Knife Radiosurgery for Acromegaly

International Journal of Endocrinology - Tập 2012 - Trang 1-7 - 2012
John D. Rolston1, Lewis S. Blevins2,1
1Department of Neurological Surgery, University of California San Francisco, San Francisco, CA 94143-0112, USA
2California Center for Pituitary Disorders, University of California, San Francisco, San Francisco, CA 94143-0350, USA

Tóm tắt

Acromegaly is debilitating disease occasionally refractory to surgical and medical treatment. Stereotactic radiosurgery, and in particular Gamma Knife surgery (GKS), has proven to be an effective noninvasive adjunct to traditional treatments, leading to disease remission in a substantial proportion of patients. Such remission holds the promise of eliminating the need for expensive medications, along with side effects, as well as sparing patients the damaging sequelae of uncontrolled acromegaly. Numerous studies of radiosurgical treatments for acromegaly have been carried out. These illustrate an overall remission rate over 40%. Morbidity from radiosurgery is infrequent but can include cranial nerve palsies and hypopituitarism. Overall, stereotactic radiosurgery is a promising therapy for patients with acromegaly and deserves further study to refine its role in the treatment of affected patients.

Từ khóa


Tài liệu tham khảo

2010, Neurosurgical Focus, 29

2010, Neurosurgical Focus, 29

2010, Neurosurgical Focus, 29

2008

10.1210/jc.2009-2570

1999, Pituitary, 2, 29, 10.1023/A:1009965803750

10.1111/j.1365-2265.2009.03667.x

10.1210/jc.2006-1668

10.1111/j.1365-2265.2008.03221.x

2010, Neurosurgical Focus, 29

10.1007/s11154-007-9064-y

1996, Metabolism, 45, 27

10.1530/eje.0.1510317

10.1530/eje.0.1500473

10.1111/j.1365-2265.2007.02917.x

10.1111/j.1365-2265.2007.03067.x

10.1210/jc.2004-1093

10.1210/jc.83.2.374

10.1210/jc.2010-2443

2010, Neurosurgical Focus, 29

1987, European Journal of Clinical Investigation, 17, 354, 10.1111/j.1365-2362.1987.tb02200.x

10.1210/jc.79.2.461

10.1159/000317314

10.1159/000218323

10.1056/NEJM200004203421604

10.1530/eje.1.02312

10.1210/jc.2009-1239

10.1210/jc.2010-1742

10.1530/eje.1.02079

2009

2010

1995, Current Problems in Cancer, 19, 265

10.1210/jc.2009-2670

10.1530/EJE-07-0189

10.1002/ana.21558

10.1016/j.jocn.2008.09.023

10.1210/jc.85.3.1287

10.3171/jns.2007.106.5.833

2002, Journal of Neurosurgery, 97, 525, 10.3171/jns.2002.97.3.0525

10.3171/jns.2005.102.s_supplement.0119

10.1159/000151717

10.1016/j.jocn.2009.05.040

10.1111/j.1365-2265.2009.03589.x

10.1530/EJE-09-0493

10.1186/1756-9966-28-36

10.1007/s11060-009-9832-5

10.1210/jc.2008-0135

10.1227/01.neu.0000333298.49436.0e

10.1111/j.1365-2265.2006.02513.x

10.1210/jc.2005-0311

10.1210/jc.2002-021663

2003, Yonsei Medical Journal, 44, 602, 10.3349/ymj.2003.44.4.602

2003, Neurosurgical Focus, 14

2003, Neurosurgery, 53, 51, 10.1227/01.NEU.0000068702.00330.47

2001, Journal of Neurosurgery, 95, 285, 10.3171/jns.2001.95.2.0285

10.1159/000066721

2000, Journal of Neurosurgery, 93, 19

2000, Journal of Neurosurgery, 93, 2

10.1159/000048393

1999, Stereotactic and Functional Neurosurgery, 72, 125, 10.1159/000056448

1999, Stereotactic and Functional Neurosurgery, 72, 119, 10.1159/000056447

1999, Stereotactic and Functional Neurosurgery, 72, 101, 10.1159/000056445

1999, Stereotactic and Functional Neurosurgery, 72, 88, 10.1159/000056444

10.1159/000056412

1998, Stereotactic and Functional Neurosurgery, 70, 110, 10.1159/000056413

10.1159/000056415

10.1159/000056414

1996, Yonsei Medical Journal, 37, 165, 10.3349/ymj.1996.37.3.165